Results 31 to 40 of about 644,370 (183)
This article is concerned with both standard (estrogen and progesterone receptors, Her2/neu and Ki67) immunohistochemical investigation in hormonal therapy tactics decision for luminal breast cancer and additional investigation of such hormonal ...
I. M. Bondarenko +8 more
doaj +1 more source
AROMATASE INHIBITORS-TYPES AND ADVANTAGES [PDF]
The role of aromatase inhibitors in the management of breast cancer has been promising as it markedly suppresses the production of estrogen. The inhibitors are very effective in postmenopausal women and used as the first-line therapy for hormone ...
C., SUDANDIRADOSS, C., BENEDICT PAUL
core +1 more source
Dual aromatase-steroid sulfatase inhibitors
By introducting the steroid sulfatase inhibitory pharmacophore into aromatase inhibitor 1 (YM511), two series of single agent dual aromatase-sulfatase inhibitors (DASIs) were generated. The best DASIs in vitro (JEG-3 cells) are 5, (IC50(aromatase) = 0.82
Chander, S.K. +8 more
core +4 more sources
Aromatase inhibitors and antiepileptic drugs: a computational systems biology analysis
Background The present study compares antiepileptic drugs and aromatase (CYP19) inhibitors for chemical and structural similarity. Human aromatase is well known as an important pharmacological target in anti-breast cancer therapy, but recent research ...
Mustata Gabriela, Muftuoglu Yagmur
doaj +1 more source
Role of aromatase inhibitors in breast cancer [PDF]
Primarily, the role of the aromatase inhibitors has been investigated in postmenopausal women with breast cancer, although it is also now being assessed in premenopausal patients following ovarian ablation/suppression.
Carpenter, R +3 more
core +1 more source
Introduction: Aromatase inhibitors are hormonal therapies used in menopausal breast cancer with positive progesterone receptors and/or estrogen receptors.
Desak Gede Agung Suprabawati +4 more
doaj +1 more source
A novel series of 1,2,3-triazole/1,2,4-triazole hybrids 5a, 5b, and 6a–i was designed and synthesized as antiproliferative agents targeting aromatase enzymes.
Mohamed T-E Maghraby +5 more
doaj +1 more source
Sequencing of aromatase inhibitors [PDF]
Since the development of the third-generation aromatase inhibitors (AIs), anastrozole, letrozole and exemestane, these agents have been the subject of intensive research to determine their optimal use in advanced breast cancer. Not only have they replaced progestins in second-line therapy and challenged the role of tamoxifen in first-line, but there is
openaire +2 more sources
Aromatase activity has commonly been associated with male infertility characterized by testicular dysfunction with low serum testosterone and/or testosterone to estradiol ratio.
Francesco Del Giudice +8 more
doaj +1 more source
Aromatase Inhibitors as a Promising Direction for the Search for New Anticancer Drugs
Aromatase is an enzyme that plays a crucial role in the biosynthesis of estrogens, which are hormones that contribute to the growth of certain types of breast cancer.
Sara Janowska +3 more
doaj +1 more source

